Marianne Fillion provides insights about the Precision Medicine and Diagnostics market research function at Purdie Pascoe. She delves into technological advancements, the competitive oncology landscape and why market research is so important for development and implementation in this space.

Watch this webcast in which Director and Precision Medicine expert Marianne Fillion reveals how market research can unlock integral insights such as key customer trends, product adoption and patient leakage.

Tumor agnostic indications present specific challenges that must be addressed to achieve a successful launch and ensure wide access for all patients. To prepare for these complex product and indications launches, it is paramount for commercial teams to gain insights on tumor agnostic testing behaviors, including awareness, adoption, drivers and barriers.

There are over 300 million people living with a rare disease across the globe, and they need help. Purdie Pascoe is dedicated to partnering with life science companies to make timely, informed decisions, and help improve the lives of those affected by rare diseases worldwide.